Dr. Edward P. Monaghan
Angestellt, President/Owner, SOAR Pharmaceutical Development Services
Rancho Santa Margarita, Vereinigte Staaten
Werdegang
Berufserfahrung von Edward P. Monaghan
Bis heute 16 Jahre und 6 Monate, seit 2008
Vice President, Clinical Operations
TRF Pharma, Inc.; Burlingame, CA
Responsible for generation of INDs, interactions with the FDA, and development and oversight of clinical programs for a novel treatment of pain caused by sickle cell disease.
Bis heute
President/Owner
SOAR Pharmaceutical Development Services
6 Monate, Mai 2007 - Okt. 2007
Head, Clinical & Regulatory
N.V. Organon; Irvine, CA
Part of Organon transition team following acquisition of Kadmus' technology.
2002 - 2007
Vice President, Drug Development
Kadmus Phamaceuticals, Inc.
Responsible for generation of INDs and CTAs, interactions with the FDA and TPD, and development and oversight of preclinical toxicology and clinical programs for novel CNS-active compounds for therapeutic indications including pain, depression, and anxiety. Led to successful sale of the technology, valued at up to $150 MM.
1992 - 2002
Senior Medical Research Specialist
Serono, Inc., Norwell, MA
Led an international Phase III tria (EVIDENCE) comparing two active treatments for MS. Directed clinical, data management, biostatistics, and regional CRA activities. Managed a $40MM study budget and surpassed very aggressive timelines.
1995 - 1999
Associate Director, Clinical Research
CoCensys, Inc.; Irvine, CA
Led development activities for novel treatment of epilepsy that included presenting to FDA, NIH, and potential partners, preparing INDs and IBs, designing and implementing Phase I and II trials, hiring and training clinical staff, and establishing intra- and inter-departmental Standards Operating Procedures.
1992 - 1995
Principal Clinical Research Associate
Allergan Inc.; Irvine, CA
Led Phase II and IV studies in neuro-rehabilitation, including protocol development, site selection/initiation, contract negotiation, investigator meetings, monitoring, data analysis, and report writing.
Sprachen
Englisch
-